Central African Republic vs Peru: Average cost of tuberculosis treatment by type
Central African Republic
43 constant 2022 US$
in 2024
Peru
43 constant 2022 US$
in 2024
Central African Republic rank
13th
Peru rank
13th
Average cost of tuberculosis treatment by type over time
- Central African Republic
- Peru
How they compare
Central African Republic currently reports 43 constant 2022 US$ against 43 constant 2022 US$ in Peru, a difference of 0 constant 2022 US$.
Across all 5 years both countries report, Peru has been ahead every year.
Central African Republic ranks 13th and Peru ranks 13th of 62 countries.
Peru has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Central African Republic | Peru | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 10 constant 2022 US$ | 60 constant 2022 US$ | 50 constant 2022 US$ | Peru |
| 2020s | 34.75 constant 2022 US$ | 53.25 constant 2022 US$ | 18.5 constant 2022 US$ | Peru |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher average cost of tuberculosis treatment by type, Central African Republic or Peru?
- Central African Republic, at 43 constant 2022 US$ against 43 constant 2022 US$ in Peru as of 2024.
- What is the difference in average cost of tuberculosis treatment by type between Central African Republic and Peru?
- 0 constant 2022 US$, with Central African Republic ahead.
- How many years of comparable data are there for Central African Republic and Peru?
- 5 years are reported by both, from 2019 to 2024.
- How do Central African Republic and Peru rank globally for average cost of tuberculosis treatment by type?
- Central African Republic ranks 13th and Peru ranks 13th of 62 countries.
- Where does this data come from?
- WHO (2025) – with minor processing by Our World in Data, published as Average cost of tuberculosis treatment by type. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Average cost of drugs spent per person starting tuberculosis preventive treatment, excluding buffer stock.